|Last Price$35.96||Day Change (%)-0.03%|
|Open Price$36.10||Day Change ($)-0.01|
|Day Range35.77–36.12||52-Week Range29.83–36.21|
As of Fri 9/22/2017 6:54:00 PM | USD
Lysogene Announces First Half 2017 Financial Results and Business Update
ETFs provide a great means to gain exposure to this battered health-care giant.
We believe breakups could unlock value for big pharma shareholders.
Things look grim, but investors who can bear it could benefit.